Trial Profile
Monocenter prospective open single-arm phase IV study of the effects of hawthorn extract WS® 1442 on arterial micro-vascular structure and macro-vascular function, persistance and erectile function of male patients with underlying cardiovascular disease and erectile dysfunction
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 07 Oct 2021
Price :
$35
*
At a glance
- Drugs Crataegus (Primary)
- Indications Heart failure
- Focus Pharmacodynamics
- Sponsors Dr. Willmar Schwabe Pharmaceuticals
- 05 Oct 2021 Status changed from suspended to discontinued.
- 04 Apr 2020 Status changed from recruiting to suspended.
- 10 Oct 2016 Status changed from not yet recruiting to recruiting.